TrialEuropean journal of clinical pharmacology2014

Effects of vercirnon on the activity of CYP3A4, CYP2C19 and CYP2C8 enzymes and BCRP and OATP1B1 transporters using probe substrates.

Lynda J Haberer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.